22 related articles for article (PubMed ID: 21832868)
1. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
Hayashida Y; Nomata K; Noguchi M; Eguchi J; Koga S; Yamashita S; Hayashi M; Kanatake H
Urology; 2004 Jun; 63(6):1084-8. PubMed ID: 15183955
[TBL] [Abstract][Full Text] [Related]
2. Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?
Giannarini G; Kessler TM; Birkhäuser FD; Thalmann GN; Studer UE
Eur Urol; 2011 Nov; 60(5):955-60. PubMed ID: 21807456
[TBL] [Abstract][Full Text] [Related]
3. [Treatment outcome of intrarenal Bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract].
Anan G; Suyama T; Takeuchi N; Nakamura K; Sakamoto S; Nihei N; Ichikawa T
Hinyokika Kiyo; 2013 May; 59(5):261-4. PubMed ID: 23719131
[TBL] [Abstract][Full Text] [Related]
4. [Intracavitary bacillus Calmette-Guerin therapy for upper tract transitional cell carcinoma].
Mori H; Miyaji B; Takahashi M; Matsuda K; Tsuka H; Wada O; Aoki Y; Akino H; Muranaka K; Kanamaru H; Okada K; Imamura Y
Hinyokika Kiyo; 1996 Apr; 42(4):257-61. PubMed ID: 8693956
[TBL] [Abstract][Full Text] [Related]
5. [Percutaneous Bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ].
Yamashita S; Yogi Y; Taniguchi K; Morimitsu H; Suzu H; Kanetake H; Saito Y; Kubota S
Hinyokika Kiyo; 1992 Oct; 38(10):1095-9. PubMed ID: 1481770
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: a systematic review.
Casey RG; Catto JW; Cheng L; Cookson MS; Herr H; Shariat S; Witjes JA; Black PC
Eur Urol; 2015 May; 67(5):876-88. PubMed ID: 25466937
[TBL] [Abstract][Full Text] [Related]
7. [Upper urinary tract tumors: endourological management and treatment].
de Fata FR; González J; Angulo J
Arch Esp Urol; 2011 Apr; 64(3):279-88. PubMed ID: 21502699
[TBL] [Abstract][Full Text] [Related]
8. Intracavitary immunotherapy and chemotherapy for upper urinary tract cancer: current evidence.
Carmignani L; Bianchi R; Cozzi G; Grasso A; Macchione N; Marenghi C; Melegari S; Rosso M; Tondelli E; Maggioni A
Rev Urol; 2013; 15(4):145-53. PubMed ID: 24659911
[TBL] [Abstract][Full Text] [Related]
9. [Long-term outcome of initial treatment with Bacillus Calmette-Guérin for carcinoma in situ of the upper urinary tract].
Kita Y; Soda T; Mizuno K; Matsuoka T; Nakanishi S; Asai S; Taoka R; Inoue K; Terai A
Hinyokika Kiyo; 2011 Jul; 57(7):353-7. PubMed ID: 21832868
[TBL] [Abstract][Full Text] [Related]
10. [Intrarenal bacillus Calmette-Guerin therapy for carcinoma in situ of the upper urinary tract].
Okubo K; Ishitoya S; Maeda H; Suzuki Y; Arai Y
Nihon Hinyokika Gakkai Zasshi; 1997 Mar; 88(3):386-90. PubMed ID: 9125861
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
